Embed Size (px)
Citation preview
CANADIAN PHARMACY SERVICES FRAMEWORK
October 2011
Shared Pan-Canadian Vision for Pharmacy
“Optimal Drug Therapy Outcomes for
Canadians through Patient-Centered Care”
— Blueprint for Pharmacy Vision Statement
The Blueprint for Pharmacy is a collaborative initiative designed to catalyze, coordinate and facilitate the changes required to align pharmacy practice with the health care needs of Canadians and to achieve the Vision for the future of pharmacy in Canada. The Blueprint is led by the Canadian Pharmacists Association, as Secretariat for the National Coordinating Office. A Steering Committee, comprised of representatives from national and provincial pharmacy organizations, monitors and facilitates implementation.
2
What is the Canadian Pharmacy Services Framework?
• The Canadian Pharmacy Services Framework (CPSF) is an
implementation project of the Blueprint for Pharmacy, developed in
collaboration between CACDS, CPhA and provincial pharmacy
associations
• It outlines a roadmap to deliver increased patient-centred care –
pharmacy services that are cost-effective, and based on the needs of
Canadians and value to the healthcare system
• The Framework recognizes the value of professional pharmacy
services while ensuring a financially viable and sustainable pharmacy
business model – it provides a method and understanding for
establishing fees for different categories of services
• The Framework supports the development of financially-viable services
that are scalable across jurisdictions – it is intended to be adapted to
align with jurisdictional needs
4
Guiding Principles of the Framework
• Pharmacy services are patient-centred, cost-effective, and are based on
the needs of patients and value to the healthcare system
• Therapeutic outcomes are optimized through enhanced interprofessional
collaboration and communication
• The Framework creates a common approach to describing and
understanding professional pharmacy services
• The Framework aligns with existing pharmacists’ standards of practice
and with emerging scope of practice activities (see Appendix I: mapping
of CPSF to NAPRA Model Standards of Practice)
• Provinces can adapt and implement the Framework in alignment with
jurisdictional scopes of practice, healthcare priorities and available
resources
• Pharmacists will practice in accordance with jurisdictional legislation and
policy, and recognized standards and scope of practice
• The Framework creates a common, unified and strong voice for
pharmacy across Canada
5
Pharmacy Services: Ideal Final State…
CACDS CPhA CSHP NAPRA PPAs PRAs AFPC Government Payers
Pharmacy practice includes patient-centred services
that are harmonized, scalable and sustainable
• Adapted for each
province
• Funded appropriately
by payers with an
acceptable ROI
• Value demonstrated
through innovative
services
• Enhanced health
outcomes for
Canadians
• Desired by patients
• Implemented by
pharmacists
• Integrated
technology solutions
• Enhanced
interprofessional
collaboration
• Coordinated with
educators and
researchers
6
Pharmacy Services: the FRAMEWORK
7
Creating a Framework for Pharmacy Services
8
Patient-centred care is enabled by regulations that
support the delivery of expanded services and
provide access to information:
o Pharmacist prescribing (initiate, adjust, discontinue)
o Medication injection
o Ordering lab tests
Creating a Framework for Pharmacy Services
1. Core Dispensing Services*
Ph
arm
acis
ts’ S
erv
ices
• Provision of prescribed medication (appropriate, safe, effective,
accurate)
• Assess for adverse drug events, interactions, allergies
• Assess for accessibility (e.g., formulary coverage, affordability)
• Patient dialogue
• Patient call-back
Fac
tors
• Prescription-focused
• Reimbursement: professional fee per Rx
• Workflow driven
• Impact of pharmacy technician regulation
* These services are not all inclusive of the dispensing process; they are focused
on the pharmacist’s therapeutic role in core dispensing services, to ensure safe,
appropriate and effective medication therapy; they do not include technically-
focused, non-clinical dispensing services. 9
2. Enhanced Medication-Related Services
Ph
arm
ac
ists
’ S
erv
ice
s • Additional prescription intervention if required:
o Adapting Rx
o Therapeutic Substitution
o Renewing Rx for continuity of care of chronic medications
o Pharmaceutical Opinion
o Refusal to Fill
o Emergency Prescribing
o Adherence monitoring and compliance programs
• Personal medication record – medication reconciliation
• Medication injection
Fac
tors
• Workflow adjustment required
• Reimbursement: Fee-for-Service
• May lead to referral to other healthcare professionals (HCP)
• Toolkit required – to facilitate implementation
Creating a Framework for Pharmacy Services
10
Creating a Framework for Pharmacy Services
3. Expanded Patient Care Services
Ph
arm
acis
ts’ S
erv
ices
• Comprehensive Medication
Management (CMM): o Assessment
o Drug-related problems (DRPs)
identified & resolved
o Care Plan developed
o Monitor & follow-up
• Management of Minor Ailments : o Assessment
o Triage/referral
o Treatment
o Monitor & follow-up
• Health Promotion – Disease
Prevention o Immunization
o Disease screening
o Smoking cessation
o Wellness – lifestyle
Facto
rs
• Appointment based
• Workflow adjustment required
• Interprofessional collaboration and documentation
• May lead to referral to other healthcare professionals (HCP)
• Reimbursement: Resource Based Relative Value Scale (RBRVS) & Fee-for-Service
• Toolkit required – to facilitate implementation
11
Comprehensive Medication Management
Assessment
• Interview patient &
create database
• Review medication for
indication,
effectiveness, safety,
and adherence
• List drug-related
problem(s) & prioritize
Create and
Implement Care Plan
• Goal of therapy
• Intervention and/or
referral
• Plan for follow-up
Evaluation
• Monitor results
• Documentation
• Continuous follow-up
• Possible referral of patient to
physician, another pharmacist or
other healthcare professional
• Interventions directly with patients
• Interventions via collaboration
(physician and other healthcare
professionals)
Pharmacy services
and/or interventions
Reassess
as needed
This slide has been adapted from the Medication Therapy Management (MTM) format outlined by the American Pharmacists
Association and National Association of Chain Drug Stores 12
COMPENSATION
The Evolving Pharmacy Economic Model
Funding for Core Dispensing Services
Cost of
medication
Dispensing
services fee
Processing
charge,
commercial
terms
Health system
access
allowance
(where
applicable)
Funding for Additional Professional Services
Enhanced Medication-Related Services
Expanded Patient Care Services
14
Potential Funding Models
• Resource-Based Relative Value
Scale (RBRVS)
• Fee-for-Service (FFS)
• Fee for Time
• Primary care health team
15
Funding Considerations
• Must consider pharmacist’s time to provide service and follow-up
o Need Standard Operating Procedures (SOPs) to estimate time
requirements across jurisdictions
• Services may be provided to patients as the need arises
• Consideration should be given to the accountability of the pharmacist in
providing patient care
• What other costs does the service save the healthcare system?
o Additional physician visits, ER visits, hospital admissions
• Consideration of evolving funding models of other healthcare
professionals
16
DESCRIPTION OF SERVICES
17
Specific Pharmacy Services
• Adapting a Prescription
• Therapeutic Substitution
• Prescribing in an Emergency
• Refusal to Fill
• Administration of a Medication by Injection and Immunization
• Comprehensive Medication Management
• Interpreting and Ordering Laboratory Tests
• Minor Ailments Assessment and Management
• Medication Reconciliation
• Chronic Disease Management
NOTE: the timelines indicated for each individual service are approximate
and may vary based on patient, workflow, regulatory factors, etc.
18
Adapting a Prescription
• For existing prescriptions:
o Pharmacist may alter the dosage, formulation, duration or
regimen without prescriber consent but with patient consent, and
follow up with an update to the prescriber
o Pharmacist must meet all ethical, legal and regulatory
requirements involved in this patient care activity
19
Adapting a Prescription: BENEFITS
Patients
• Optimizes therapeutic
outcomes for patients
o Improves efficacy & safety
o Adherence
o More efficient access to
medication
o Improves access to
treatment
Prescribers
• Reduces burden on physicians and
other healthcare professionals
Payers
• Reduce employee absenteeism as a
result of efficient resolution of
prescription issues
• May contribute to cost-reduction within
drug plans
Health System
• Efficient and effective health care system
• Optimizing use of health human resources
• Potential for cost containment and cost avoidance for the overall healthcare system
20
Adapting a Prescription:
Standard Operating Procedures
• Key considerations o Applies to all pharmacists
• Training o May require training for therapeutic
substitution
• Location requirements o Privacy
• Equipment and supplies requirements o Documentation tools
• Technology requirements o Integrated documentation
• Documentation requirements
• Patient education, monitoring and follow-up
• Provider notification when required/relevant
21
Adapting a Prescription: WORKFLOW
• Need to consider medication, dose, route, regimen for appropriateness;
as well as availability of the medication and cost/coverage
Patient
Assessment
Identify Drug-Related
Problem (DRP)
Gather Information
Adapt Prescription
Educate Document + Follow-up
22
Therapeutic Substitution
• For existing prescriptions:
o Pharmacist can substitute a drug within a defined therapeutic
class (e.g., provincial formulary), substituting another drug that
is expected to have an equivalent therapeutic effect with the
goal of meeting the patient’s therapeutic goal
o Pharmacist must meet all ethical, legal and regulatory
requirements for this patient care activity
23
Therapeutic Substitution: BENEFITS
Patients
• Optimizes therapeutic
outcomes for patients
o Improves efficacy & safety
o Adherence
o More efficient access to
medication
o Improves access to
treatment
Prescribers
• Reduces burden on physicians and
other healthcare professionals
Payers
• Reduce employee absenteeism as a
result of efficient resolution of
prescription issues
• May contribute to cost-reduction within
drug plans
Health System
• Efficient and effective healthcare system
• Optimizing use of health human resources
• Potential for cost containment and cost avoidance for the overall healthcare system
24
Therapeutic Substitution:
Standard Operating Procedures
• Training o May require training for therapeutic
substitution
• Location requirements o Privacy
• Equipment and supplies requirements o Documentation tools
• Technology requirements o Integrated documentation
• Documentation requirements
• Patient education, monitoring and
follow-up
• Provider notification when
required/relevant
25
Therapeutic Substitution: WORKFLOW
Patient
Assessment Identify DRP
Gather Information
Therapeutic Substitution
Educate Document + Follow-up
26
Prescribing in an Emergency
In the absence of an existing prescription, but when there is an
immediate need for drug therapy (in an emergency), a community
pharmacist can prescribe a Schedule 1 drug:
o When it is not reasonable, according to the pharmacist’s
professional judgment, for the patient to seek emergency healthcare
elsewhere
o When there is an immediate, high-risk to the patient’s health if
immediate treatment is not provided (e.g., asthmatic attack,
anaphylactic reaction)
o The pharmacist will only prescribe the minimum amount to safely
treat the immediate need until medical care can be sought
o The pharmacist must meet all ethical, legal and regulatory
requirements involved in this patient care activity
o Narcotics and controlled medications cannot be prescribed
27
Prescribing in an Emergency: BENEFITS
Patients
• Provides immediate healthcare
access to patients
• Improves efficacy & safety
• Optimizes therapeutic outcomes
for patients by providing efficient
access to medications
Prescribers
• Encourages collaboration amongst
healthcare providers to provide quality
healthcare to patients
Payers
• Reduce employee absenteeism as a result
of efficient resolution of prescription issues
• Employers could see reduction in overall
healthcare costs
Health System
• Reduces the burden on emergency rooms
• Promotes an efficient and effective healthcare system
• Makes the best use of human resources in the healthcare system
28
Prescribing in an Emergency:
Standard Operating Procedures
• Key considerations o Applies to all pharmacists
• Training
• Location requirements
• Equipment and supplies requirements o Assessment guide, prescription pads
• Technology requirements o Integrated documentation
• Documentation requirements
• Patient education, monitoring and
follow-up
• Provider notification when required/
relevant
29
Prescribing in an Emergency: WORKFLOW
Patient
Assessment
Gather Information
Create Emergency Prescription
Monitor (as needed)
Document + Follow-up
30
Refusal to Fill
• Pharmacists may choose NOT to dispense a prescription when in
their professional judgment it is deemed not to be in the patient’s
best interest
• Reasons may include but are not limited to: o Significant drug interaction (drug-to-drug)
o Prior adverse reaction
o Therapeutic duplication
o Sub-therapeutic dose
o Dangerously high dose
o Treatment failure
o Potential overuse/abuse
o Suspected poly-pharmacy/multi-doctoring
o Falsified/altered prescription
o Consulted prescriber – changed dose
o Consulted prescriber – changed instructions for use
Note: This service does not include refusal to fill for moral reasons or early refills. 31
Refusal to Fill: BENEFITS
Patients
• Optimizes therapeutic
outcomes for patients
o Reduces the risk of
overuse, underuse or
other inappropriate use
of medications
Prescribers
• Improves medication safety and
effectiveness
• Leverages the educational and professional
competencies of pharmacists as medication
experts.
Payers
• Prescriptions not dispensed which could have
a negative outcome for patients.
• Prevents prescription drug wastage
Health System
• Addresses the increasing concerns about overutilization, diversion, hospitalization for
drug-related problems
• May decrease overall healthcare costs as a result 32
Refusal to Fill:
Standard Operating Procedures
• Drug utilization review & assessment
• Training
• Equipment and supplies requirements o Standardized documentation forms
• Technology requirements o Integration of claim transmission,
credit and billing
• Documentation requirements
• Patient education, monitoring and
follow-up
• Provider collaboration and notification
33
Refusal to Fill: WORKFLOW
Patient
Assessment
Identify Need
Gather Information
Prescription intervention
Educate Document + Follow-up
34
Administration of a Medication by Injection
and Immunization
• A qualified/authorized pharmacist may administer a
medication by injection:
o Pursuant to either an existing prescription, or as needed in
an emergency, or within a collaborative or independent
prescribing framework
o As delegated by provincial public health agencies
Note: Jurisdictional/regulatory restrictions apply (e.g., may be limited
to immunization only)
35
Administration of a Medication by Injection
and Immunization: BENEFITS
Patients
• Optimizes therapeutic outcomes for patients
o Improves patient adherence to
therapy
o Provides quicker and more efficient
access to medication and vaccines
o Improves choice, convenience and
access to treatment and immunization
o Fills gaps that may exist where other
providers are not available within a
community
Prescribers
• Reduces burden on physicians
and other healthcare
professionals
Payers
• May reduce absenteeism as a
result of increased access to
immunization (e.g., mass
vaccination clinics in the
workplace) and routine
injectable medications
Health System
• Improves vaccination rates as a result of better access and increased promotion
• Decreases wait times 36
Administration of a Medication by Injection and
Immunization: Standard Operating Procedures*
• Personnel qualifications o First aid, CPR, hepatitis B
• Training o As required by pharmacy regulatory
authority
• Location requirements o Cold chain, patient seating
• Equipment and supplies requirements o Injection supplies
• Technology requirements o Integrated documentation
• Documentation requirements
• Provider collaboration and/or notification
• Patient education, monitoring and
follow-up (patient consent) 37
* SOPs may vary as per jurisdictional
and regulatory requirements
Patient
Assessment
Identify Need
Gather Information
Inject Medication
Educate & Observe Patient
Document + Follow-up
Administration of a Medication by Injection and
Immunization: WORKFLOW
38
Comprehensive Medication Management (CMM)
• A patient-centred, systematic process of: o Patient assessment
o Assessment of medication therapies for appropriateness,
effectiveness, safety and adherence
o Identification of drug-related problems
o Create and implement care plan, with patient
o Collaboration and communication with other healthcare
professionals
o Evaluation, documentation and continuous follow-up
• For more complex patients requiring ongoing monitoring and
follow-up, and at transitions of care
• Can include: o Chronic disease prevention and management
o Performing a medication reconciliation or best possible medication
history
o Pharmacist prescribing
o Ordering/evaluating lab tests
39
Comprehensive Medication Management (CMM)
Assessment
• Interview patient &
create database
• Review medication for
indication,
effectiveness, safety,
and adherence
• List drug-related
problem(s) & prioritize
Create and
Implement Care Plan
• Goal of therapy
• Intervention and/or
referral
• Plan for follow-up
Evaluation
• Monitor results
• Documentation
• Continuous follow-up
• Possible referral of patient to
physician, another pharmacist or
other healthcare professional
• Interventions directly with patients
• Interventions via collaboration
(physician and other healthcare
professionals)
Pharmacy services
and/or interventions
Reassess
as needed
This slide has been adapted from the Medication Therapy Management (MTM) format outlined by the American Pharmacists
Association and National Association of Chain Drug Stores 40
Patients
• Optimizes therapeutic outcomes
for patients
o Appropriate medication use
o Adherence
o Awareness of medication and
treatment needs
o Knowledge and
empowerment
• Optimizes patient understanding
of their medication:
o Transitions of care
o New medication regimens
o Multiple conditions or
medications
o History of non-adherence
o Limited health literacy
o Financial constraints
Prescribers
• Reduces burden on physicians and other healthcare
professionals
• Ensures prescribers have access to a best possible
medication history
Payers
• Private insurance companies and employers can
access pharmacy services to improve health
outcomes for their employees
Health System
• Efficient and effective healthcare system
• Optimizes human resources
• Improves collaboration amongst providers
• Contributes to medication error prevention
Comprehensive Medication Management: BENEFITS
41
• Key considerations o Consistent definition of the service
o Can involve medication review to obtain
best possible medication history
• Training o New or advanced patient assessment skills
• Location requirements o Privacy
• Equipment and supplies requirements o Filing of documentation, forms
• Technology requirements o Automation, patient health record
• Documentation requirements o Consider all stakeholders
• Patient education, monitoring and follow-up o Patient consent
• Provider collaboration o Follow-up as required
Comprehensive Medication Management:
Standard Operating Procedures
42
• Patient care provided over time
• Initial appointment may be 60 minutes or longer; follow-up appointments
can be less
• May be managed as part of the dispensing or independent of filling a
prescription in an appointment-based counseling session
Patient
Assessment
Perform assessment
Identify Drug-
Related Problems
Document and
prioritize DRPs
Create and implement care plan
Document and notify prescriber, other HCPs
Comprehensive Medication Management: WORKFLOW
43
Interpreting and Ordering Laboratory Tests
• As part of the process of Comprehensive Medication Management,
pharmacists collect and apply relevant information to help respond
to the patient’s health needs; this includes laboratory data
o The pharmacist accepts the responsibility and accountability for the
application of the laboratory data collected
o Laboratory data should be accessible to pharmacists via the patient’s
electronic health record; in the absence of such EHR access, the
pharmacist will apply due diligence to avoid duplication
o The pharmacist takes appropriate action based on results (e.g.,
recommends treatment; communicates with other providers or refers
the patient for follow-up where appropriate)
o The pharmacist must remain competent in the interpretation of
laboratory data
o Use of laboratory data for dosage adjustments or diagnosis is
subject to jurisdictional regulations
44
Patients
• Optimizes outcomes for patients
o Ensures that drug and dose are
appropriate for the individual
o Monitors response to therapy
o Monitors for adverse drug effects
o Screens patients for untreated health
conditions
Prescribers
• Allows physicians and other HCPs to focus
on those patients that require their
expertise
• Reduces burden on physicians and other
providers
Payers
• Monitoring and timely intervention to
identify/resolve drug-related problems
resulting in decreased absenteeism.
Health System
• Creates efficiencies with timely interventions and referrals
• Reduces adverse effects (enhanced patient safety) and associated costs of treating them
• Reduces complications (and associated costs) with more specific therapeutic monitoring of chronic
conditions.
Interpreting and Ordering Laboratory Tests: BENEFITS
45
• Key considerations o For monitoring drug therapy; not to diagnose
o Need to avoid duplication of lab tests
o Time required for coordination with other
providers
• Training o How to order lab data, interpret data
• Location requirements o Privacy
• Technology requirements o Ordering lab data and laboratory receipt of
pharmacist’s lab orders
• Documentation requirements
• Patient education, monitoring and follow-up
• Provider collaboration o Communicate to/from primary care provider
Interpreting and Ordering Laboratory Tests:
Standard Operating Procedures
46
Interpreting and Ordering Laboratory Tests: WORKFLOW
Patient
Assessment
Identify Need
Gather Information
Order &/or Interpret Lab Tests
Further Intervention
based on Results
Document + Follow-up
47
Minor Ailments Assessment and Management
• Pharmacists can assess symptoms and prescribe for the
treatment of certain minor and self-diagnosed ailments, as
determined by legislation/regulations
o The minor ailments that can be treated vary from jurisdiction to
jurisdiction (e.g., head lice, coughs, colds, allergies, rashes, cold
sores, hay fever)
o A pharmacist is authorized to assess the patient’s self-diagnosed
condition, and prescribe from a defined list of medications
o The pharmacist recommends treatment or refers to the another
healthcare provider, if unable to confirm the patient’s diagnosis
and/or the patient’s symptoms are severe
48
Patients
• Optimizes therapeutic outcomes for
patients
o Enhances patient’s ability to self-
manage minor ailments
o Provides more efficient access to
healthcare professional and faster
assessment
o Improves choice, convenience and
access to treatment, and timely
referral to another HCP if needed
o Fills gaps that may exist where other
providers are not available within a
community
Prescribers
• Focus on more seriously ill patients
• See patients that have been assessed,
triaged and referred by pharmacist
• Reduces burden on physicians and other
healthcare professionals
Payers
• Reduce employee absenteeism as a
result of timely assessment and
management of self-limiting conditions
• Earlier intervention may contribute to
cost-reduction
Health System
• Improves utilization of human resources, reduces stress on walk-in clinics, family physicians, urgent
care facilities and emergency rooms
• Improves access to primary care, in particular during evenings and weekends, and results in a more
efficient patient care process
Minor Ailments Assessment and Management: BENEFITS
49
• Key considerations o Provincial minor ailments service definitions
(e.g., formulary, list of minor ailments)
• Training o The pharmacist must remain competent in
the assessment of minor ailments and be
knowledgeable about established treatment
protocols
• Location requirements
o Privacy
• Technology requirements
o Integrated documentation
• Documentation requirements
• Patient education, monitoring and follow-up
• Provider collaboration
o Refer to physician or other HCP, if required
Minor Ailments Assessment and Management:
Standard Operating Procedures
50
Patient
Assessment
Identify Need
Gather Information
Refer or initiate therapy
Educate Document + Follow-up
Minor Ailments Assessment and Management: WORKFLOW
51
Medication Reconciliation
• Medication reconciliation (MedRec) is the provision and
maintenance of an accurate and current record of what
medications a patient is taking (best possible medication history
– BPMH)
o it requires comparison and reconciliation of prescriber-ordered
medications versus what the patient is taking
• Medication reconciliation is a practice designed to prevent
medication errors and adverse drug events from occurring when
patients are at risk for problems with their medications, e.g.,
o at transition points in care, such as admission to, or discharge
from, a hospital
o complexity of medication regimes
o change in physicians
52
Medication Reconciliation: BENEFITS
Patients
• Optimizes therapeutic
outcomes for patients
o Reduces the risk of
adverse events and
potential patient harm
o Prevents misuse,
overuse or underuse of
medications
Prescribers
• Improves medication safety and
effectiveness
• Leverages the educational and professional
competencies of pharmacists as medication
experts through collaborative efforts
Payers
• Decreased absenteeism as adherence to
prescribed treatment enhanced
Health System
• Addresses the increasing concerns about overutilization, diversion, hospitalization for
drug-related problems
• Enhanced patient outcomes may decrease overall healthcare costs as a result 53
• Key considerations o Consistent definition of the service
o Can result in more detailed medication review
• Training o New or advanced patient assessment skills
• Location requirements o Privacy
• Equipment and supplies requirements o Filing of documentation, forms
• Technology requirements o Automation, patient health record
• Documentation requirements o As per regulatory and program policies
• Patient education, monitoring and follow-up o Patient consent
• Provider collaboration o Follow-up as required
Medication Reconciliation:
Standard Operating Procedures
54
Patient
Assessment
Identify Need
Gather Patient’s
Medication History
Reconciliation of medication
Information given to patient &
prescriber
Document, & follow-up; notify prescriber, other
HCPs
Medication Reconciliation: WORKFLOW
55
Medication Reconciliation: WORKFLOW (cont’d)
• Creation of the patient’s best possible
medication history (BPMH) via interview of
patient, family and/or other healthcare
practitioners, and documentation
• Comparison of BPMH and the prescriber’s
current orders, with the goal of identifying,
preventing, and resolving drug-related
problems (DRPs)
• Documentation of discrepancies between
the BPMH and the prescriber’s orders
• Reconciliation of medications within a
specified time frame
• Communication of information in a clear
and concise form to the next healthcare
provider and patient
56
Chronic Disease Management
• Pharmacists apply the principles of comprehensive
medication management to optimize drug therapy and
improve outcomes
o An interprofessional, collaborative approach to managing
patients with chronic long-term illness (e.g., diabetes,
hypertension, heart disease, lung disease)
o It may include the provision of enhanced services such as a
medication therapy review
57
Patients
• Improves health outcomes by empowering
the patient and optimizing drug therapy
outcomes
• Identifies patients at risk
• May contribute to slower disease
progression
• Increases awareness and understanding of
disease and its management
Prescribers
• Shared responsibility in managing patients
with chronic disease
• Pharmacist’s drug therapy expertise is
utilized in a collaborative care approach
Payers
• Cost savings through better management
of chronic disease, as such patients are
high users of the healthcare system
• Decreased absenteeism and increased
productivity when disease is better
managed
• More cost-effective drug therapy
Health System
• Contributes to more cost effective use of healthcare dollars
• Results in more effective use of human resources (collaborative, patient-centred approach)
• Can result in earlier detection and prevention of disease, slowing the progression and resultant
costs
Chronic Disease Management: BENEFITS
58
• Key considerations o Applies principles of comprehensive
medication management
• Training o Specialized areas of practice
• Location requirements o Privacy
• Equipment and supplies requirements o Filing of care plans and medication records
• Technology requirements o Integrated documentation
• Documentation requirements
• Patient education, monitoring and follow-up o Patient consent
• Provider collaboration o Shared patient chart
Chronic Disease Management:
Standard Operating Procedures
59
• Workflow as per Comprehensive Medication Management
• An initial variable investment of time and resources are required to set
up this service, as outlined below
Choose
disease
state and
identify
patients
Stakeholder analysis
Comprehensive Medication
Management
Medication Therapy Review or
other enhanced services
Collaborate Prepare your practice
Chronic Disease Management: WORKFLOW
60
IMPLEMENTATION OF PHARMACY SERVICES
61
Overall Implementation Considerations
• Change management issues:
o Delineation of technical dispensing functions from pharmacists’
clinical services related to dispensing
o Understanding and acknowledgement of pharmacists’ role in patient
care by other healthcare professionals
o Promotion and patient education regarding the scope of a
pharmacist’s capabilities
o Pharmacist focus on patient outcomes and ongoing monitoring of
patient over time
o Pharmacist acceptance of accountability
o Pharmacist vision of self as a primary care provider
o Availability of regulated pharmacy technicians to provide additional
time for pharmacists’ medication management services
o Change in workflow and scheduling appropriate time for
pharmacists’ clinical services
62
Overall Implementation Considerations (cont’d)
• Other factors:
o Access to and documentation of relevant patient care information
in health records
o Enabling pharmacy practice legislation and regulations
o Pharmacist therapeutic knowledge, training and ongoing
professional development
o Availability of suitable patient consultation area
o Patient consent
o Integrated clinical services technology solution with a common
platform using standard data classifications
63
Description of Pharmacy Services TEMPLATE
Framework
Element Description
Description A brief description of the activity in simple terms
Responsibility Role of who will provide or oversee the activity, and accountability for service
Eligibility Patients for whom the activity is provided
Desired Benefits/Value How the activity will add value to the patient, the healthcare system, payers
and the population
Standard Operating
Procedures (SOPs)
Key considerations, personnel qualifications, training, requirements of location,
equipment, technology, quality indicators and process mapping
Time Estimate Window for amount of time with patient, preparation, and follow-up
Compensation Recommended compensation model most well suited for achieving desired
outcomes
Change Management Potential change management issues with pharmacists, physicians, other
HCPs, patients, the public
Other Factors Environmental, infrastructure, capacity or regulatory barriers
Technology
Considerations
Pharmacy practice development should be aligned with an integrated patient
technology solution.
This Template can be used as a standardized tool to further describe
specific services that are being implemented in a jurisdiction.
64
Role & Considerations TEMPLATE
Role Jurisdictional Considerations
Pharmacist
Technician/Assistant
Pharmacy Manager
Pharmacy
Patient
Prescription
This Template can be used as a standardized tool to further describe
service requirements, eligibilities and other considerations specific to a
particular jurisdiction
65
SUMMARY
66
• The Canadian Pharmacy Services Framework (CPSF) is an
implementation project of the Blueprint for Pharmacy, developed in
collaboration between CACDS, CPhA and provincial pharmacy
associations
• It outlines a roadmap to deliver increased patient-centred care –
pharmacy services that are cost-effective, and based on the needs of
Canadians and value to the healthcare system
• The Framework recognizes the value of professional pharmacy services
while ensuring a financially viable and sustainable pharmacy business
model
• CPSF supports the development of financially-viable services that are
scalable across jurisdictions – Provinces can adapt and implement the
Framework to align with jurisdictional scopes and standards of practice,
healthcare priorities and available resources
• Standard operating procedures will help to ensure that professional
services are delivered and measured consistently across the country
Summary
67
For further information, contact:
Janet Cooper, CPhA
613-523-7877 x 255
Steve Wilton, CACDS
416–226-9100 x 224
Canadian Pharmacy Services Framework
Mapping to the National Association of Pharmacy
Regulatory Authorities’ (NAPRA) Model Standards of Practice for Canadian Pharmacists (MSOP)
CPSF – Appendix I
NAPRA Model Standards of Practice (MSOP)
Mapping to CPSF
• MSOP were released by the National Association of
Pharmacy Regulatory Authorities’ (NAPRA) in March 2009.
• MSOP are minimum standards of practice that all
pharmacists must meet.
• Implicit in the description of the pharmacy services in the
CPSF document is the need for pharmacists to meet or
exceed NAPRA’s MSOP in order to optimize their delivery
of direct patient care.
• The following table maps only the MSOP that relate directly
relate to the services identified in the CPSI Framework.
CPSF Service Applicable Model Standard of Practice (NAPRA)
Adapting a
Prescription
10. Rectify prescriptions for medications that patients are taking for the
first time that pose risks to a patient by: • Making changes to the prescription in accordance with authorities granted
to pharmacists by laws/regulations/policies/guidelines, and/or
• Contacting the prescriber to recommend changes in the prescription,
and/or
• Refusing to dispense the prescription
11. Assess the appropriateness of providing a refill of a medication
requested by a patient by collecting and interpreting relevant patient
information to ensure: • There are no significant drug interactions, contra-indications or adverse
effects, and
• The medication is still required, and
• The dose and instructions for use of the medication are correct, and
• That the patient is receiving appropriate monitoring for this medication and
disease
12. Manage patient’s requests for refills of medications which pose
risks to the patient by: • Making changes to the prescription in accordance with authorities granted
to pharmacists by law/regulations/policies/guidelines, and/or
• Contacting a prescriber to recommend changes in the prescription, and/or
• Refusing to dispense the medication
CPSF Service Applicable Model Standard of Practice (NAPRA)
Adapting a
Prescription (continued)
13. Assess the patient’s compliance when providing refills for
medications for treatment of chronic disease
14. Address problems with compliance that pose risks to the patient or
can affect the efficacy of the medication by: • Educating the patient, and
• Making changes to their medications and/or medication therapies in
accordance with authorities granted to pharmacists by
laws/regulations/policies/guidelines, or
• Contacting a prescriber or recommend changes in therapy
15. Extend refills on medications for chronic disease only: • Under conditions specified by, and in accordance with authorities granted
to pharmacists by applicable laws/regulations/policies/guidelines, and
when it is in the patient’s best interest to do so
16. Extend refills on medications for chronic disease appropriately,
having collected and interpreted relevant patient information to
ensure: • The patient’s chronic condition is sufficiently stable to warrant extension
without evaluation by physician, and
• There are no significant drug interactions, contra-indications or adverse
effects, and
• The medication is still required, and
• The dose and instructions for use of the medication are correct, and
• That the patient is receiving appropriate monitoring for this medication
and chronic disease
CPSF Service Applicable Model Standard of Practice (NAPRA)
Prescribing in
an Emergency
20. Prescribe medications independently or according to collaborative
prescribing agreements, protocols, delegation agreements or
medical directives only: • Under conditions specified by, and in accordance with authorities granted
to pharmacists by, applicable laws/regulations/ policies/ guidelines, and
• When it is in the patient’s best interest to do so
21. Prescribe medications based on the pharmacist’s own
assessment of the patient only having collected and interpreted
relevant patient information to ensure: • There are no significant drug interactions or contra-indications, and
• The medication is the most appropriate in view of patient characteristics,
signs and symptoms, other conditions and medications, and
• The dose and instructions for use of the medication are correct.
CPSF Service Applicable Model Standard of Practice (NAPRA)
Administration
of a Medication
by Injection
33. Administer medications by injection only: • In accordance with authorities granted to pharmacists by
laws/regulations/policies/guidelines, and
• When there are policies and procedures established for handling
emergencies
• The environment in which the injection is to be administered is
appropriate, and
• The pharmacist can take all appropriate steps to ensure that the
injection is administered safely
CPSF Service Applicable Model Standard of Practice (NAPRA)
Interpreting
and Ordering
Laboratory
Tests
30. Order laboratory tests for patients and/or access patient’s
laboratory results: • Only under conditions specified by applicable laws/regulations
/policies/guidelines, and
• Only when it is in the patient’s best interest to do so, and
• When necessary to ensure that a patient’s medication therapy is
safe and effective
31. Interpret patient’s laboratory results to identify if patients need
changes to their medication therapy
32. Manage required changes to patient’s medication therapy as
identified via interpretation of laboratory results by: • Making changes in therapy in accordance with authorities granted to
pharmacists by laws/regulations/policies/guidelines, or
• Contacting a prescriber to recommend changes in therapy
CPSF Service Applicable Model Standard of Practice (NAPRA)
Comprehensive
Medication
Management
26. Complete medication reviews with patients who are at risk of
experiencing problems with their medications to identify: • Significant drug interactions, contra-indications or adverse effects,
and
• Medications which are no longer required, and
• Incorrect dose or instructions for medication use, and
• Noncompliance, and
• Lack of appropriate monitoring for medications being used
27. Rectify medication-therapy problems that pose risks to the
patient or can affect the efficacy of the medication by: • Educating the patient, and
• Making changes in therapy in accordance with authorities granted to
pharmacists by laws/regulations/ policies/guidelines, or
• Contacting a prescriber to recommend changes in therapy
